BDB001
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BDB001, covering 2025-10-06 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors [Phase 2]